Arrowhead Research reported $139.92M in Cash and Equivalent for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 127.44M 22.58M
Alnylam Pharmaceuticals ALNY:US $ 496.58M 0.12M
Arena Pharmaceuticals ARNA:US $ 219.54M 240.6M
Arrowhead Research ARWR:US $ 139.92M 3.66M
Bluebird Bio BLUE:US $ 317.7M 6.46M
Cerulean Pharma CERU:US $ 5.39M 0.04M
Dicerna Pharmaceuticals DRNA:US $ 126.02M 78.26M
Heron Therapeutics HRTX:US $ 105.14M 10M
Intercept Pharmaceuticals ICPT:US $ 58.15M 12.84M
Ligand Pharmaceuticals LGND:US $ 47.62M 409.3M
Merk MRK:US $ 8062M 706M
Mirati Therapeutics MRTX:US $ 865.16M 752.54M
Moderna Inc MRNA:US 2.62B 1.12B
Nektar Therapeutics NKTR:US $ 198.96M 143.11M
Novartis NOVN:VX SF 9658M 664M
Opko Health OPK:US $ 72.21M 35.92M
Spectrum Pharmaceuticals SPPI:US $ 77.13M 7.99M
Ultragenyx Pharmaceutical RARE:US $ 713.53M 516.04M
Vertex Pharmaceuticals VRTX:US $ 5988.19M 630.1M
Xencor XNCR:US $ 163.54M 105.45M
YTE INCY:US $ 1513.01M 15.23M